$RLFTF Bogo DD clip from CC: Bogo1 minute ago “
Post# of 653
(Total Views: 271)
Posted On: 03/29/2021 8:53:48 AM
$RLFTF Bogo DD clip from CC: Bogo1 minute ago
“Expectations going forward”: “Bringing hope to life” is the corporate motto. They were surprised how the 28 day data was spun negatively by the media. Public should not expect them to use the language of a multi-billion dollar BP company. This top line data is being reported 4 weeks after treating the last patient in the 60 day window. Do not take anything negative from delay of data. No implication of data difference between regional hospitals and tertiary hospitals. (He is obviously reading, which is good, from a statement - you can hear the paper turning).
This natural 28 amino acid peptide does what man made drugs don’t do.
Validated use of Zyesami with portable nebulizer in home.
Signed agreement with I-SPY for trial. Signed agreement with National Institute of Health for a trial. FDA has approved use of Zyesami in those trials.
CVD lungs have entered the vocabulary. Chronic lung injury, well known from CVD and smoke inhalation with firefighters, and voluntary inhalation. Cystic and Pulmonary Fibrosis communities are asking the company to explore treating those conditions.
“Expectations going forward”: “Bringing hope to life” is the corporate motto. They were surprised how the 28 day data was spun negatively by the media. Public should not expect them to use the language of a multi-billion dollar BP company. This top line data is being reported 4 weeks after treating the last patient in the 60 day window. Do not take anything negative from delay of data. No implication of data difference between regional hospitals and tertiary hospitals. (He is obviously reading, which is good, from a statement - you can hear the paper turning).
This natural 28 amino acid peptide does what man made drugs don’t do.
Validated use of Zyesami with portable nebulizer in home.
Signed agreement with I-SPY for trial. Signed agreement with National Institute of Health for a trial. FDA has approved use of Zyesami in those trials.
CVD lungs have entered the vocabulary. Chronic lung injury, well known from CVD and smoke inhalation with firefighters, and voluntary inhalation. Cystic and Pulmonary Fibrosis communities are asking the company to explore treating those conditions.
(0)
(0)Mondobiotech Holding AG Basel (RLFTF) Stock Research Links
$MJ